Position in SLXN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$765
-$3,075 QoQ
Shares Held
300
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 6 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SLXN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MONTAG A & ASSOCIATES INC holds $1,116,311 across 17 Biotechnology names. SLXN ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
852 | $423,213 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
750 | $213,727 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
5,013 | $195,557 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
194 | $104,168 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
137 | $85,424 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
542 | $47,126 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
80 | $19,277 | |
| 8 | NKTR |
Nektar Therapeutics
|
250 | $17,452 |
All Filings in SLXN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $765 | 300 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $3,840 | 3,000 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $5,760 | 3,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $10,200 | 3,000 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||